Ozempic Could Be Much less Efficient for Emotional Eaters, Research Suggests

GLP-1 agonists—so-called “wonder medicine” like Ozempic or Wegovy that assist people decrease blood sugar ranges and drop extra pounds, amongst different issues—yield vital outcomes for some sufferers, however not all. Individuals’s motivations to overeat could play a job on this, in accordance with a brand new research.

To research why some individuals don’t profit from GLP-1 agonists as a lot as others, researchers noticed 92 contributors with sort 2 diabetes in Japan throughout their first yr of taking GLP-1 medicine. Their results, revealed right now in Frontiers in Scientific Diabetes and Healthcare, recommend that individuals who overeat attributable to exterior causes—such because the sight or odor of scrumptious meals—had larger probabilities of responding properly to the medicine in the long run than individuals who overeat for emotional causes.

Who will profit most from GLP-1 medicine?

“Pre-treatment evaluation of consuming conduct patterns could assist predict who will profit most from GLP-1 receptor agonist remedy,” Daisuke Yabe, senior creator of the research and a professor of diabetes, endocrinology, and diet at Kyoto College, stated in a Frontiers assertion. “GLP-1 receptor agonists are efficient for people who expertise weight achieve or elevated blood glucose ranges attributable to overeating triggered by exterior stimuli. Nevertheless, their effectiveness is much less anticipated in circumstances the place emotional consuming is the first trigger.”

The crew revealed this by gathering information on the contributors’ physique weight and composition, eating regimen, and knowledge equivalent to blood glucose, levels of cholesterol, and relationship with meals originally of the remedy, three months after, and one yr after. They centered on emotional consuming (consuming in response to adverse feelings), exterior consuming (consuming as a result of the meals seems to be good), and restrained consuming (controlling one’s eating regimen to drop extra pounds). Whereas it might sound contradictory, extreme restrained consuming can really end in disordered consuming, in accordance with the researchers.

Over the yr, the contributors skilled a statistically vital lack of physique weight and lowered levels of cholesterol and physique fats share with out altering skeletal muscle mass. Whereas blood glucose ranges ameliorated, the development wasn’t statistically vital. There have been, nevertheless, some variations relying on consuming behaviors. Three months after the beginning of the remedy, contributors reported extra restrained consuming and fewer exterior or emotional consuming. By the top of the yr, although, contributors had returned to their unique restrained and emotional consuming habits.

“One attainable rationalization is that emotional consuming is extra strongly influenced by psychological components which might not be immediately addressed by GLP-1 receptor agonist remedy,” stated Takehiro Kato, second creator of the article and a researcher from Gifu College, “People with outstanding emotional consuming tendencies could require extra behavioral or psychological help.”

Exterior consuming lessened over the yr of remedy

Contributors reported decreased exterior consuming all through all the yr, and people that claimed excessive ranges of exterior consuming originally of the remedy noticed the best advantages in blood glucose ranges and weight reduction. Alternatively, the crew didn’t establish any affiliation between emotional or restrained consuming scores originally and drug advantages by the 12-month mark.

“Whereas our research suggests a possible affiliation between exterior consuming conduct and remedy response to GLP-1 receptor agonists, these findings stay preliminary,” defined Yabe. What’s extra, the crew’s research was observational, and contributors self-reported info, which means the researchers revealed a possible affiliation, not a causation.

“Additional proof is important earlier than they are often carried out in scientific apply. Ought to future large-scale or randomized managed trials validate this relationship, incorporating easy behavioral assessments may grow to be a beneficial part in optimizing remedy methods,” Yabe concluded.